Introduction

Cancer does not always strike randomly. For many people, the risk of developing certain cancers is written in their DNA — passed down silently through generations. Genetic testing for cancer risk has transformed modern oncology, making it possible to identify high-risk individuals before cancer ever develops. From the well-known BRCA1 and BRCA2 mutations to a broader range of hereditary cancer genes, understanding your genetic makeup can be a life-saving decision.

If you have a strong family history of cancer or belong to a high-risk group, consulting a genetic testing specialist or medical oncologist in Mysore could be one of the most important steps you take for your long-term health.

What Is Genetic Testing for Cancer Risk?

Genetic testing examines your DNA — the chemical database that carries instructions for your body's functions — to identify mutations or changes in specific genes that are linked to an elevated cancer risk. These inherited mutations do not mean you will definitely develop cancer, but they significantly raise the probability compared to the general population.

A simple blood or saliva sample is all that is needed. The results can reveal whether you carry mutations in genes associated with breast cancer, ovarian cancer, colorectal cancer, pancreatic cancer, and several other cancer types.

Understanding BRCA1 and BRCA2 Mutations

The most well-researched hereditary cancer genes are BRCA1 and BRCA2 (short for Breast Cancer gene 1 and 2). Under normal conditions, these genes act as tumor suppressors — they produce proteins that help repair damaged DNA and prevent cells from growing uncontrollably.

When a mutation occurs in BRCA1 or BRCA2, this protective function is lost, and the risk of certain cancers rises dramatically:

• BRCA1 mutation: Lifetime breast cancer risk up to 72%; ovarian cancer risk up to 44%
• BRCA2 mutation: Lifetime breast cancer risk up to 69%; also linked to pancreatic cancer, prostate cancer, and melanoma

These mutations are inherited in an autosomal dominant pattern — meaning one copy of the altered gene in each cell is sufficient to increase cancer risk. Men who carry BRCA2 mutations are also at higher risk for breast and prostate cancer.

Early detection through genetic counseling and regular screening can dramatically improve outcomes for BRCA mutation carriers. Many individuals in Mysore with a family history of these cancers are now proactively seeking genetic testing as part of their preventive care routine.

Beyond BRCA: Other Hereditary Cancer Genes

While BRCA1 and BRCA2 get the most attention, they are just two of many genes associated with hereditary cancer syndromes. Modern multi-gene panel testing can now screen for dozens of mutations simultaneously. Key genes beyond BRCA include:

Lynch Syndrome Genes (MLH1, MSH2, MSH6, PMS2)

Lynch syndrome is the most common hereditary colorectal cancer syndrome. Mutations in these mismatch repair genes raise the risk of colorectal, endometrial, ovarian, stomach, and urinary tract cancers. Individuals with Lynch syndrome have up to an 80% lifetime risk of colorectal cancer.

TP53 — Li-Fraumeni Syndrome

Mutations in the TP53 tumor suppressor gene are associated with Li-Fraumeni syndrome, a rare but serious condition that dramatically raises the risk of multiple cancer types, including sarcomas, breast cancer, brain tumors, and leukemia, often at a young age.

PALB2

A partner gene to BRCA2, PALB2, mutations significantly increase the risk of breast and pancreatic cancer. Carriers may have a lifetime breast cancer risk comparable to that of BRCA1 carriers.

CDH1

Mutations in CDH1 are linked to hereditary diffuse gastric cancer and lobular breast cancer. Carriers often face a very high lifetime risk of stomach cancer.

APC — Familial Adenomatous Polyposis (FAP)

APC gene mutations cause FAP, a condition where hundreds of polyps develop in the colon, almost always leading to colorectal cancer if left untreated.

CHEK2, ATM, RAD51C, RAD51D

These are moderate-risk genes associated with breast, ovarian, and other cancers. While the risk elevation is less dramatic than BRCA, it is still clinically significant, especially when combined with other risk factors.

Who Should Consider Genetic Testing?

Genetic testing is not recommended for everyone — it is most valuable for individuals with specific risk indicators. You may benefit from cancer genetic testing if you:

• Have a first-degree relative (parent, sibling, or child) diagnosed with cancer at a young age (under 50)
• Have multiple relatives on the same side of the family with the same or related cancers
• Have a personal or family history of breast, ovarian, colorectal, or uterine cancer
• Are of Ashkenazi Jewish descent, as BRCA mutations are significantly more prevalent in this population
• Have a family member who has already tested positive for a hereditary cancer mutation
• Were diagnosed with triple-negative breast cancer under age 60
• Have a male relative diagnosed with breast cancer

A qualified medical oncologist or genetic counselor can evaluate your personal and family history to determine whether genetic testing is appropriate for you.

What Happens After Genetic Testing?

Receiving genetic test results — whether positive or negative — requires careful interpretation and follow-up planning.

If the test is positive: A positive result means you carry a mutation that increases cancer risk. This does not mean you have cancer. Your oncologist will work with you to develop a personalized surveillance and risk-reduction plan, which may include:

• Enhanced screening: More frequent mammograms, MRIs, colonoscopies
• Chemoprevention: Medications like tamoxifen that can lower breast cancer risk
• Risk-reducing surgery: In some cases, preventive (prophylactic) mastectomy or oophorectomy is considered
• Lifestyle modifications: Diet, exercise, and avoidance of environmental triggers

If the test is negative: A negative result is reassuring but does not eliminate cancer risk, as not all hereditary mutations are currently known. Routine screening based on age and general risk factors should continue.

Variant of Uncertain Significance (VUS): Sometimes a genetic change is found whose effect is not yet fully understood. In such cases, your oncologist will monitor new research and revisit the findings as more data becomes available.

The Role of Genetic Counseling

Genetic testing should always be accompanied by professional genetic counseling — before and after the test. A genetic counselor helps you understand the implications of your results, addresses your emotional concerns, and guides family members who may also be at risk. Leading oncology centers in Mysore now integrate genetic counseling as part of comprehensive cancer care.

Genetic Testing and the Indian Population

Cancer genetic testing in India is still evolving, but awareness is growing rapidly. Studies suggest that BRCA1 and BRCA2 mutations in Indian women may have distinct variants compared to Western populations. This underscores the importance of population-specific research and access to genetic testing services across India, including cities like Mysore, where expert oncologists are now offering these advanced diagnostic services.

Conclusion

Genetic testing for cancer risk is no longer a tool reserved for elite medical centers in metro cities. As awareness grows and testing becomes more accessible, individuals across India — including those seeking expert oncology care in Mysore — have the opportunity to take control of their cancer risk before symptoms ever appear. From BRCA mutations to Lynch syndrome genes and beyond, understanding your hereditary risk is one of the most powerful steps you can take in the fight against cancer.

If you have a strong family history of cancer or simply want to understand your genetic risk better, speak with a qualified medical oncologist today.

FAQs: Genetic Testing for Cancer Risk

Q1. Is genetic testing available in Mysore?
Yes. Dr. Naveen Jayaram Anvekar at Apollo BGS Hospitals, Mysore, offers evaluation, genetic testing referrals, and personalized risk counseling.

Q2. Does a positive BRCA test mean I'll get cancer?
No. It means your risk is elevated, not certain. With proactive screening and preventive measures, the risk can be managed effectively.

Q3. How much does cancer genetic testing cost in India?
Multi-gene panel testing typically costs ₹15,000–₹50,000, depending on the genes tested and the laboratory used.

Q4. Can men benefit from genetic testing?
Yes. Men with BRCA2 mutations face higher risks for prostate, pancreatic, and male breast cancer. Lynch syndrome affects both genders equally.

Q5. At what age should I get tested?
Generally recommended for adults (18+) who meet clinical risk criteria based on personal or family cancer history.